Health Tech Capitol | Vectura and Propeller Health announce collaboration to develop digitally-connected inhalers to address chronic respiratory diseases
15340
post-template-default,single,single-post,postid-15340,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Vectura and Propeller Health announce collaboration to develop digitally-connected inhalers to address chronic respiratory diseases

24 May Vectura and Propeller Health announce collaboration to develop digitally-connected inhalers to address chronic respiratory diseases

Posted at 10:36h in Uncategorized by
0 Likes

CHIPPENHAM, United Kingdom and MADISON, Wis., May 24, 2016 /PRNewswire/ — Vectura Group plc (LSE: VEC) and Propeller Health, the leading digital health solution for respiratory medicine, today announced a collaboration to develop inhalers that combine Vectura’s proven dry powder inhaler (“DPI”) technology with Propeller’s FDA-cleared digital health platform.

Vectura is a leading respiratory pharmaceutical company providing a range of pre-metered foil blister-based dry powder inhalers developed to meet patients’ needs in inhalation therapy. The initial focus of the collaboration will be the development of an add-on sensor for Vectura’s lever-operated multi-dose inhaler (LOMI). Patients with a Propeller-connected LOMI device will be more engaged with their care and better equipped to understand their disease and improve self-management.

Read more at PRNewswire

No Comments

Sorry, the comment form is closed at this time.